Extracorporeal shock wave therapy in the treatment of Peyronie's disease: Long term results

Archivio Italiano di Urologia e Andrologia

Volumn 82, Issue 2, 2010, Pages 128-133

  De Berardinis, Ettore ^a   Busetto, Gian Maria ^a   Antonini, G ^a   Giovannone, R ^a   Gentile, V ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

ESWT (Extracorporeal Shock Wave Therapy); Penile recurvatum; Peyronie's disease

Indexed keywords

ADULT; AGED; ARTICLE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; EXTRACORPOREAL LITHOTRIPSY; FOLLOW UP; HEMATOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN; PENIS; PENIS ERECTION; PEYRONIE DISEASE; RELIABILITY; RIGIDITY; SEXUAL INTERCOURSE; SHOCK WAVE; THERAPY EFFECT; TREATMENT DURATION; URETHRAL BLEEDING; CLINICAL TRIAL; LITHOTRIPSY; MIDDLE AGED; PENILE INDURATION; PROSPECTIVE STUDY; TIME; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; HUMANS; LITHOTRIPSY; MALE; MIDDLE AGED; PENILE INDURATION; PROSPECTIVE STUDIES; TIME FACTORS; YOUNG ADULT;

EID: 77955820986     PISSN: 11243562     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Brock G, Hsu GL, Nunes L, et al. The anatomy of the tunica albuginea in the normal penis and Peyronie's disease. J Urol 1997; 157:276-281. (Pubitemid 26414973)
2. Weidner W, Schroeder-Printzen I, Weiske WH. Sexual dysfunction in Peyronie's disease: an analysis of 222 patients without previous local plaque therapy. J Urol 1997; 157:325-328.
3. Mulhall JP, Creech SD, Boorjian SA, et al. Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screening. J Urol 2004; 171:2350-2353.
4. Lin GT, Wang Z, Liu BC, et al. Identification of potential biomarkers of Peyronie's disease. Asian J Androl 2005; 7:237-243.
5. Levine LA, Lenting EL. A surgical algorithm for the treatment of Peyronie's disease. J Urol 1997; 158:2149-2152.
6. Leungwattanakiij S, Tiewthanom V, Hellstrom WJ. Evaluation of corporal fibrosis in cadaveric pericardium and vein grafts for tunica albuginea substitution in rats. Asian J Androl 2003; 54:295-299.
7. Chahal R, Gogoi NK, Sundaram SK, et al. Corporal plication for penile curvature caused by Peyronie's disease: the patients' perspective. BJU Int 2001; 87:352-356. (Pubitemid 32240848)
8. El-Sakka A, Lue TF. Peyronie's disease. Curr Opin Urol 1998; 8:203-209.
9. Bellorofonte C, Ruoppolo M, Tura M, et al. Possibility of using the piezoelectric lithotriptor in the treatment of severe cavernofibrosis. Arch Ital Urol Nefrol Androl 1989; 61:417-422.
10. Heist J, von Keitz-Steeger D. Stosswelleentherapie knochennaher Weichteilschmerzen - Ein neues Behandlungskonzept; in Chaussy C, Einsenberger D, Jocham D, Wilbert D (eds.). Die Stosswelle - Forshung und Klinik. Tubingen, Attempto 1995; 162-168.
11. Taylor FL, Levine LA. Peyronie's disease. Urologic Clinics of North America; 34:517-34.
12. Haupt G. Stosswellen in der Orthopadie. Urologe A 1997; 36:233-238.
13. Haupt G. Use of extracorporeal shock waves in the treatment of the pseudarthrosis, tendinopathy and other orthopedic diseases. J Urol 1997; 158:4-11. (Pubitemid 27251584)
14. Hauck EW, Altinkilic BM, Ludwig M, et al. Extracorporal Shock Wave Therapy in the treatment of Peyronie's disease. Eur Urol 2000; 38:663-670.
15. Bahren W, Stief CG. Intrakavernose Pharmakontestung - SKAT- Test: in Bahren W, Altenwein JE (eds.): Impotenz, Stuttgard; Thieme. Urologe 1988; 25:164-165.
16. Levine LA, Estrada CR, Storm DW, et al. Peyronie disease in younger men: characteristics and treatment results. J Androl 2003; 24:27-32.
17. Ehrlich HP. Scar contracture: cellular and connective tissue aspects in Peyronie's disease. J Urol 1997; 157:316-319.
18. Devine CJ Jr. Introduction to the international Conference on Peyronie's disease. J Urol 1997; 157:272-275.
19. Furlow WL, Swenson HE, Lee RE. Peyronie's disease: a study of its natural history and treatment with orthovoltage radiotherapy. J Urol 1975; 114.69-71.
20. Gelbard MK, Dorey F, James K. The natural history of Peyronie's disease. J Urol 1990; 144:1376-1379.
21. Abdel-Salam Y, Budair Z, Renner C, et al. Treatment of Peyronie's disease by extracorporeal shockwave therapy: evaluation of our preliminary results. J Endourol 1999; 13:549-552.
22. Hamm R, McLarty E, Ashdown J, et al. Peyronie's disease - the Plymouth experience of extracorporeal shochwave treatment. BJU Int 2001; 87:849-852. (Pubitemid 34204328)
23. Husain J, Lynn N, Jones DK, et al. Extracorporeal shock wave therapy in the management of Peyronie's disease: initial experience. BJU Int 2000; 86:466-468.
24. Kiyota H, Ohishi Y, Asano K, et al. Extracorporeal shock wave treatment for Peyronie's disease using EDAP Lt-02; preliminary results. Int J Urol 2002; 9:110-113.
25. Manikandan R, Islam W, Srinivasan V, et al. Evaluation of extracorporeal shock wave therapy in Peyronie's disease. Urology 2002; 60:795-799.
26. Mirone V, Imbimbo C, Palmieri A, et al. Our experience on the association of a new physical and medical therapy in patients suffering from induratio penis plastica. Eur Urol 1999; 36:327-330.
27. Hauck EW, Hauptmann A, Bschleiper T, et al. Questionable efficacy of extracorporeal shock wave therapy for Peyronie's disease: results of a prospective approach. J Urol 2004; 171:296-299.